Advancing treatments for rare diseases together

Citizen's Health COST action kick-off in Brussels

27Nov

EspeRare is representing Switzerland within a European Cooperation in Science and Technology Action (COST) focused on Citizen’s Health 

Brussels, Wednesday 27th of November, as members of the management committee, Sharon Terry and Caroline Kant have kicked-off the IS1303 COST* Action called Citizen’s Health through public-private Initiative: Public health, Market and Ethical perspectives. Twenty-two countries are represented in this action that aims at developing legal and scientific guidelines in the area of Citizen Health, in particular genetic testing and screening, biobanking, health ethics and justice and public democratization of research.

*COST | Cooperation in Science and Technology is one of the longest-running European frameworks supporting cooperation among scientists and researchers across Europe